Sign In
Buy BPMC
$129.46
+0 (+0%)
At Close: Oct 17, 2025
Morgan Stanley Remains a Buy on Zealand Pharma (ZEAL)
03:37pm, Wednesday, 15'th Apr 2020
Morgan Stanley analyst
David Lebovitz
maintained a
Buy
rating on Zealand Pharma (
ZEAL
–
Research Report
) today and set a price target of
$37.00
. The company’s shares closed last Wednesday at $3
Alnylam's Vutrisiran Gets Fast Track Tag for hATTR Amyloidosis
03:15pm, Wednesday, 15'th Apr 2020
The FDA confers a Fast Track status on Alnylam's (ALNY) RNAi therapeutic vutrisiran for treating adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis.
Alnylam's Vutrisiran Gets Fast Track Tag for hATTR Amyloidosis
03:15pm, Wednesday, 15'th Apr 2020
The FDA confers a Fast Track status on Alnylam's (ALNY) RNAi therapeutic vutrisiran for treating adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis.
Cramer Shares His Thoughts On MGM Resorts, Starbucks And More
12:26pm, Tuesday, 14'th Apr 2020
On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't like the restaurant sector. He is not a buyer of Dine Brands Global Inc (NYSE: DIN).There are too many moving parts with working at ho
Nuveen Asset Management LLC Buys 14,661 Shares of Blueprint Medicines Corp (NASDAQ:BPMC)
09:40am, Monday, 13'th Apr 2020
Nuveen Asset Management LLC raised its stake in shares of Blueprint Medicines Corp (NASDAQ:BPMC) by 6.4% in the 4th quarter, Holdings Channel reports. The firm owned 243,847 shares of the biotechnolog
Deciphera Pharmaceuticals: Updates To Thesis, Expecting A Rebound Ahead Of August PDUFA
08:23am, Monday, 13'th Apr 2020
Shares have risen by 20% since my August update. I provide a recap of the bullish thesis. Key catalyst is PDUFA date for ripretinib in 4L/4L+ GIST in August. 2H
UBS Group AG Cuts Holdings in Blueprint Medicines Corp (NASDAQ:BPMC)
10:30am, Sunday, 12'th Apr 2020
UBS Group AG reduced its stake in shares of Blueprint Medicines Corp (NASDAQ:BPMC) by 59.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC
Macquarie Group Ltd. Has $1 Million Position in Blueprint Medicines Corp (NASDAQ:BPMC)
09:18am, Sunday, 12'th Apr 2020
Macquarie Group Ltd. lessened its holdings in shares of Blueprint Medicines Corp (NASDAQ:BPMC) by 89.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Com
Bank of America Corp DE Has $6.17 Million Holdings in Blueprint Medicines Corp (NASDAQ:BPMC)
09:04am, Saturday, 11'th Apr 2020
Bank of America Corp DE increased its stake in Blueprint Medicines Corp (NASDAQ:BPMC) by 88.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchang
Blueprint Medicines (BPMC) Upgraded to Buy: Here's Why
04:00pm, Thursday, 09'th Apr 2020
Blueprint Medicines (BPMC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Blueprint Medicines (BPMC) Upgraded to Buy: Here's Why
04:00pm, Thursday, 09'th Apr 2020
Blueprint Medicines (BPMC) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Do Hedge Funds Love RBC Bearings Incorporated (ROLL)?
04:09pm, Wednesday, 08'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Is TriNet Group Inc (TNET) A Good Stock To Buy?
04:09pm, Wednesday, 08'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Man Group plc Lowers Stock Position in Blueprint Medicines Corp (NASDAQ:BPMC)
12:42pm, Wednesday, 08'th Apr 2020
Man Group plc reduced its stake in shares of Blueprint Medicines Corp (NASDAQ:BPMC) by 37.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exc
Does Blueprint Medicines Corporation’s (NASDAQ:BPMC) CEO Pay Reflect Performance?
11:52am, Wednesday, 08'th Apr 2020
In 2014 Jeff Albers was appointed CEO of Blueprint Medicines Corporation (NASDAQ:BPMC). This analysis aims first to...
